NCT06971627Recruiting
Telehealth Monitoring in Inflammatory Bowel Disease: Effects on Medication Compliance, Self-Efficacy, and Quality of Life
The Effect of Telehealth Monitoring on Medication Compliance, Self-Efficacy and Quality of Life in Patients With İnflammatory Bowel Disease
Source: ClinicalTrials.gov · Last updated 14 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This randomized controlled trial aims to evaluate the effect of nurse-led telehealth monitoring on medication adherence, self-efficacy, and quality of life in individuals with inflammatory bowel disease (IBD). The study will be conducted at the IBD Outpatient Clinic of Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty. Participants will be randomly assigned to either an intervention group receiving a 3-month structured telehealth program (including education, counseling, phone calls, and reminders) or a control group receiving only standard care and an educational booklet. Outcomes will be assessed at baseline and after 12 weeks.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 7 May 2025
- Start date
- 20 Apr 2024
- Primary completion date
- 20 Jul 2024
- Lead sponsor
- Istanbul University - Cerrahpasa
- Diseases
- Crohn's disease, Ulcerative colitis
- NCT number
- NCT06971627
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 20 Apr 2024 to the primary completion date, 20 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients receiving infusion-based treatment
Other illness
- Diagnosed with any psychiatric or cognitive disorder
- Having any condition that impairs communication
- Having an advanced chronic disease
Other
- Pregnant women
Who the study is looking for
- Individuals aged 18 years or older
- Individuals aged 18 years or older
- Able to read and write in Turkish
- Diagnosed with inflammatory bowel disease (IBD) for at least 6 months
- In clinical remission (Harvey-Bradshaw Index score \< 5 or Simple Clinical Colitis Activity Index score \< 3)
- Able to use a smartphone
- Have access to an online messaging application (e.g., WhatsApp) and a valid e-mail address
- Capable of downloading and using a mobile or computer-based video conferencing application (e.g., Zoom)
- Willing to participate in the study voluntarily
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istanbul University - Cerrahpasa Cerrahpaşa Faculty of Medicine Department of Gastroenterology Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.